EXHIBIT 2 LEUKOSITE, INC. REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this "Agreement") is made as of July 20, 1999 by and among (i) LeukoSite, Inc., a Delaware corporation (the "Company"), (ii) Perseus Capital LLC., a Delaware...Registration Rights Agreement • July 30th, 1999 • Perseus Capital LLC • Pharmaceutical preparations • Massachusetts
Contract Type FiledJuly 30th, 1999 Company Industry Jurisdiction
JOINT FILING AGREEMENTJoint Filing Agreement • July 17th, 2000 • Perseus Capital LLC • Wholesale-drugs, proprietaries & druggists' sundries
Contract Type FiledJuly 17th, 2000 Company IndustryEach of the undersigned hereby acknowledges and agrees, in compliance with the provisions of Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, that the Schedule 13D to which this Agreement is attached as an Exhibit (the "Schedule 13D"), and any amendments thereto, will be filed with the Securities and Exchange Commission jointly on behalf of the undersigned.
EXHIBIT 1 LEUKOSITE, INC. STOCK PURCHASE AGREEMENT This STOCK PURCHASE AGREEMENT is dated as of June 22, 1999 by and between (i) LEUKOSITE, INC., a Delaware corporation with its principal office at 215 First Street, Cambridge, Massachusetts 02142 (the...Stock Purchase Agreement • July 30th, 1999 • Perseus Capital LLC • Pharmaceutical preparations • Massachusetts
Contract Type FiledJuly 30th, 1999 Company Industry Jurisdiction
EXHIBIT 1 STOCK PURCHASE AGREEMENTStock Purchase Agreement • July 17th, 2000 • Perseus Capital LLC • Wholesale-drugs, proprietaries & druggists' sundries • New York
Contract Type FiledJuly 17th, 2000 Company Industry Jurisdiction
JOINT FILING AGREEMENTJoint Filing Agreement • July 30th, 1999 • Perseus Capital LLC • Pharmaceutical preparations
Contract Type FiledJuly 30th, 1999 Company IndustryEach of the undersigned hereby acknowledges and agrees, in compliance with the provisions of Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, that the Schedule 13D to which this Agreement is attached as an Exhibit (the "Schedule 13D"), and any amendments thereto, will be filed with the Securities and Exchange Commission jointly on behalf of the undersigned.